Inflammatory myofibroblastic tumor with RANBP2 and ALK gene rearrangement with bland cytological features mimicking desmoid-type fibromatosis: A case report and review of the literature
- Authors:
- Yu‑Hua Huang
- Yu‑Feng Tian
- Chien‑Feng Li
-
View Affiliations
Affiliations: Department of Pathology, Chi‑Mei Medical Center, Tainan 710, Taiwan, R.O.C., Department of General Surgery, Chi‑Mei Medical Center, Tainan 710, Taiwan, R.O.C.
- Published online on: January 7, 2016 https://doi.org/10.3892/ol.2016.4082
-
Pages:
1429-1434
Metrics:
Total
Views: 0 (Spandidos Publications: | PMC Statistics:
)
Metrics:
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics:
)
This article is mentioned in:
Abstract
Here, we present an uncommon case of inflammatory myofibroblastic tumor (IMT) involving the mesentery. The tumor was composed of loosely arranged round‑to‑spindle‑shaped tumor cells with amphophilic cytoplasm in an inflammatory and myxoid background. The mitotic activity was low (1 per 50 high‑power fields) and the tumor cells lacked cellular atypism. Immunohistochemically, the tumor cells demonstrated strong nuclear membranous staining with anaplastic lymphoma kinase (ALK). In situ hybridization for ALK gene rearrangement revealed a splitting apart of the two signals within the tumor cells. Reverse transcription‑polymerase chain reaction revealed that the tumor harbored a ran‑binding protein 2 (RANBP2)‑ALK rearrangement. IMTs are usually characterized by epithelioid‑to‑round cells featuring increased mitotic activity, occasionally demonstrating unusual tumor cells and more aggressive clinical behavior. To date, 23 IMTs have been reported with RANBP2 and ALK gene rearrangements. However, the present case demonstrated indolent cytological features, leading to a difficulty in differentiating it from desmoid-type fibromatosis.
View References
1
|
Li J, Yin WH, Takeuchi K, et al:
Inflammatory myofibroblastic tumor with RANBP2 and
ALK gene rearrangement: a report of two cases and literature
review. Diagn Pathol. 8:1472013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen ST and Lee JC: An inflammatory
myofibroblastic tumor in liver with ALK and RANBP2
gene rearrangement: combination of distinct morphologic,
immunohistochemical, and genetic features. Hum Pathol.
39:1854–1858. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Weremowicz S and Schofield DE: Preparation
of cells from formalin-fixed, paraffin-embedded tissue for use in
fluorescence in situ hybridization (FISH) experiments. Curr Protoc
Hum Genet. 52:Chapter 8, Unit 8.8. 2007. View Article : Google Scholar
|
4
|
Ma Z, Hill DA, Collins MH, et al: Fusion
of ALK to the Ran-binding protein 2 (RANBP2) gene in
inflammatory myofibroblastic tumor. Genes Chromosomes Cancer.
37:98–105. 2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Patel AS, Murphy KM, Hawkins AL, et al:
RANBP2 and CLTC are involved in ALK
rearrangements in inflammatory myofibroblastic tumors. Cancer Genet
Cytogenet. 176:107–114. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Butrynski JE, D'Adamo DR, Hornick JL, et
al: Crizotinib in ALK-rearranged inflammatory
myofibroblastic tumor. N Engl J Med. 363:1727–1733. 2010.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Mariño-Enríquez A, Wang WL, Roy A, et al:
Epithelioid inflammatory myofibroblastic sarcoma: an aggressive
intra-abdominal variant of inflammatory myofibroblastic tumor with
nuclear membrane or perinuclear ALK. Am J Surg Pathol. 35:135–144.
2011. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kozu Y, Isaka M, Ohde Y, Takeuchi K and
Nakajima T: Epithelioid inflammatory myofibroblastic sarcoma
arising in the pleural cavity. Gen Thorac Cardiovasc Surg.
62:191–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gleason BC and Hornick JL: Inflammatory
myofibroblastic tumours: where are we now? J Clin Pathol.
61:428–437. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Meis JM and Enzinger FM: Inflammatory
fibrosarcoma of the mesentery and retroperitoneum. A tumor closely
simulating inflammatory pseudotumor. Am J Surg Pathol.
15:1146–1156. 1991. View Article : Google Scholar : PubMed/NCBI
|
11
|
Coffin CM, Watterson J, Priest JR and
Dehner LP: Extrapulmonary inflammatory myofibroblastic tumor
(inflammatory pseudotumor). A clinicopathologic and
immunohistochemical study of 84 cases. Am J Surg Pathol.
19:859–872. 1995. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lovly CM, Lipson D, Otto G, et al:
Potentially actionable kinase fusions in inflammatory
myofibroblastic tumors. Presented at ASCO Annual Meeting (abstract
10513). 2013.http://meetinglibrary.asco.org/content/115704-132
|